Syra Health Corp. Class A Common Stock
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Gregory R. Alexander
- Full Time Employees
- 89
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Address
- 1119 Keystone Way North Carmel IN United States of America 46032
- IPO Date
- Sep 29, 2023
- CIK
- 0001922335
- Website
- syrahealth.com
- Similar Companies
- Business
- Syra Health Corp is a healthcare technology company specializing in digital health solutions with a primary focus on behavioral and mental health, population health management, health education, and healthcare workforce services. It offers core products including Syrenity, an AI-backed, evidence-based mental health app integrating telehealth for managing common mental health conditions, and CarePlus, a specialized Electronic Medical Record (EMR) system designed to optimize clinical workflows and enhance patient care. The company also provides population health contract services, healthcare workforce staffing solutions, and innovative training programs targeting payers, providers, life sciences organizations, academic institutions, and government agencies across the United States. Founded in 2015 and headquartered in Carmel, Indiana, Syra Health operates nationally with contracts in multiple states including Indiana, Tennessee, Arizona, and Virginia. Recent major developments include the 2024 launch of Syrenity, which drives the company's strategic shift toward scalable mental health technology solutions, backed by positive preliminary clinical study results. The company has secured several significant contracts extending its population health and healthcare workforce engagements, such as a $2.1 million contract to provide medical management nurses for a major insurance provider and multiple government agency contracts focused on healthcare quality improvement and population health initiatives. Syra Health also achieved ISO certification and reported a 45% year-on-year revenue increase in 2024 to $8 million, driven by growth in higher-margin population health services despite overall net losses attributed to upfront investments in product development and scaling of Syrenity. Additionally, Syra Health is actively pursuing acquisitions to expand its healthcare technology portfolio and maintain its growth trajectory. The company’s strategic focus encompasses accessible, affordable, and evidence-based healthcare solutions that reduce stigmas and increase care access, aiming to support both individual users and organizational clients. Syra Health’s offerings facilitate improved mental health outcomes, operational efficiency for healthcare providers, and equitable health services for payers and government bodies, reflecting its broad commitment to advancing healthcare through technology and expertise.
Company News
Syra Health, in Partnership with HealthSync, Selected for CMS ACCESS Model, Advancing Long-Term Growth Strategy
Syra Health, Wake County Public Health Expand Wellness Partnership
Syra Health Achieves 23% Revenue Growth, Improves Gross Margin to 44.5% in Second Consecutive Profitable Quarter
Syra Health To Announce Second Quarter 2026 Financial Results
Syra Health (NASDAQ:SYRA) Trading Down 4.3% – What’s Next?
Syra Health Appoints Dr. Cori McMahon as Chief Medical Officer to Support its Growth Strategy
Syra Health Delivers its First Profitable Quarter in Q1 2026, Expands Margins and Strengthens Financial Position
Syra Health To Announce First Quarter 2026 Financial Results
Syra Health Wins Innovation of the Year and BioCrossroads Life Sciences Innovation Award at the 2026 TechPoint Mira Awards
Syra Health (NASDAQ:SYRA) Trading 4.4% Higher – Should You Buy?
Syra Health and Nora Mental Health Announce Telehealth Partnership to Expand Access to Mental and Behavioral Health Services Across Indiana
Syra Health (NASDAQ:SYRA) Trading Up 4.5% – Here’s Why
Syra Health Posts Strong FY2025 Results with 157% Population Health Growth and 76% Net Loss Reduction: Targets Profitability by Year-End 2026
Syra Health To Announce Fourth Quarter and Full Year 2025 Financial Results
Syra Health Appoints Healthcare Executive and Former U.S. Marine Gregory R. Alexander as Chief Executive Officer to Drive Growth
Syra Health Announces Third Quarter Financial Results: Margins, Profitability Metrics Improve
Syra Health To Announce Third Quarter 2025 Financial Results
Syra Health Announces Second Quarter Financial Results, Advancing Toward Profitability on Margin Gains and Cost Reductions
Syra Health To Announce Second Quarter 2025 Financial Results
Syra Health Secures Contract Valued at Up to $2.1 Million to Provide Medical Management Nurses for Major Insurance Provider